<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>6432</number>
    <updateDate>2023-11-13T20:31:11Z</updateDate>
    <updateDateIncludingText>2023-11-13T20:31:11Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2008-07-08</introducedDate>
    <congress>110</congress>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Reported by</name>
                <date>2008-07-09T18:30:05Z</date>
              </item>
              <item>
                <name>Markup by</name>
                <date>2008-07-09T18:29:51Z</date>
              </item>
              <item>
                <name>Referred to</name>
                <date>2008-07-08T18:29:09Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Reported by</name>
            <date>2008-07-30T17:49:16Z</date>
          </item>
          <item>
            <name>Markup by</name>
            <date>2008-07-16T18:51:20Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2008-07-08T18:02:00Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <committeeReports>
      <committeeReport>
        <citation>H. Rept. 110-804</citation>
      </committeeReport>
    </committeeReports>
    <actions>
      <item>
        <actionDate>2008-08-14</actionDate>
        <text>Became Public Law No: 110-316.</text>
        <type>President</type>
        <actionCode>E40000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2008-08-14</actionDate>
        <text>Became Public Law No: 110-316.</text>
        <type>BecameLaw</type>
        <actionCode>36000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2008-08-14</actionDate>
        <text>Signed by President.</text>
        <type>President</type>
        <actionCode>E30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2008-08-14</actionDate>
        <text>Signed by President.</text>
        <type>BecameLaw</type>
        <actionCode>36000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2008-08-06</actionDate>
        <text>Presented to President.</text>
        <type>Floor</type>
        <actionCode>E20000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2008-08-06</actionDate>
        <text>Presented to President.</text>
        <type>President</type>
        <actionCode>28000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2008-08-01</actionDate>
        <text>Cleared for White House.</text>
      </item>
      <item>
        <actionDate>2008-08-01</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Message on Senate action sent to the House.</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2008-08-01</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Passed Senate without amendment by Unanimous Consent. (consideration: CR S7984)</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2008-08-01</actionDate>
        <text>Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S7984)</text>
        <type>Floor</type>
        <actionCode>17000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2008-07-31</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Received in the Senate, read twice.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2008-07-30</actionDate>
        <actionTime>15:51:25</actionTime>
        <text>The title of the measure was amended. Agreed to without objection.</text>
        <type>Floor</type>
        <actionCode>H38800</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2008-07-30</actionDate>
        <actionTime>15:51:21</actionTime>
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
        <type>Floor</type>
        <actionCode>H38310</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2008-07-30</actionDate>
        <actionTime>15:51:15</actionTime>
        <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7534-7539)</text>
        <type>Floor</type>
        <actionCode>H37300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2008-07-30</actionDate>
        <actionTime>15:51:15</actionTime>
        <text>Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H7534-7539)</text>
        <type>Floor</type>
        <actionCode>8000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2008-07-30</actionDate>
        <actionTime>15:33:27</actionTime>
        <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 6432.</text>
        <type>Floor</type>
        <actionCode>H8D000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2008-07-30</actionDate>
        <actionTime>15:33:25</actionTime>
        <text>Considered under suspension of the rules. (consideration: CR H7534-7541)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2008-07-30</actionDate>
        <actionTime>15:33:08</actionTime>
        <text>Mr. Pallone moved to suspend the rules and pass the bill, as amended.</text>
        <type>Floor</type>
        <actionCode>H30300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2008-07-30</actionDate>
        <text>Placed on the Union Calendar, Calendar No. 520.</text>
        <type>Calendars</type>
        <actionCode>H12410</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <calendarNumber>
          <calendar>U00520</calendar>
        </calendarNumber>
      </item>
      <item>
        <actionDate>2008-07-30</actionDate>
        <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 110-804.</text>
        <type>Committee</type>
        <actionCode>H12200</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2008-07-30</actionDate>
        <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 110-804.</text>
        <type>Committee</type>
        <actionCode>5000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2008-07-16</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Ordered to be Reported (Amended) by Voice Vote.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2008-07-16</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2008-07-09</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Forwarded by Subcommittee to Full Committee by Voice Vote .</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2008-07-09</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Subcommittee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2008-07-08</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2008-07-08</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2008-07-08</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2008-07-08</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>P000034</bioguideId>
        <fullName>Rep. Pallone, Frank, Jr. [D-NJ-6]</fullName>
        <firstName>FRANK</firstName>
        <lastName>PALLONE</lastName>
        <party>D</party>
        <state>NJ</state>
        <district>6</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>D000355</bioguideId>
        <fullName>Rep. Dingell, John D. [D-MI-15]</fullName>
        <firstName>JOHN</firstName>
        <lastName>DINGELL</lastName>
        <party>D</party>
        <state>MI</state>
        <middleName>D.</middleName>
        <district>15</district>
        <sponsorshipDate>2008-07-08</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B000213</bioguideId>
        <fullName>Rep. Barton, Joe [R-TX-6]</fullName>
        <firstName>JOE</firstName>
        <lastName>BARTON</lastName>
        <party>R</party>
        <state>TX</state>
        <middleName>L.</middleName>
        <district>6</district>
        <sponsorshipDate>2008-07-08</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000168</bioguideId>
        <fullName>Rep. Deal, Nathan [R-GA-9]</fullName>
        <firstName>NATHAN</firstName>
        <lastName>DEAL</lastName>
        <party>R</party>
        <state>GA</state>
        <district>9</district>
        <sponsorshipDate>2008-07-08</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>T000326</bioguideId>
        <fullName>Rep. Towns, Edolphus [D-NY-10]</fullName>
        <firstName>EDOLPHUS</firstName>
        <lastName>TOWNS</lastName>
        <party>D</party>
        <state>NY</state>
        <district>10</district>
        <sponsorshipDate>2008-07-08</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000197</bioguideId>
        <fullName>Rep. DeGette, Diana [D-CO-1]</fullName>
        <firstName>DIANA</firstName>
        <lastName>DEGETTE</lastName>
        <party>D</party>
        <state>CO</state>
        <district>1</district>
        <sponsorshipDate>2008-07-10</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <cboCostEstimates>
      <item>
        <pubDate>2008-07-28T04:00:00Z</pubDate>
        <title>H.R. 6432, Animal Drug User Fee Amendments of 2008</title>
        <url>http://www.cbo.gov/publication/20116</url>
        <description>&lt;p&gt;Cost estimate for the bill as ordered reported by the House Committee on Energy and Commerce on July 16, 2008&lt;/p&gt;</description>
      </item>
      <item>
        <pubDate>2008-07-28T04:00:00Z</pubDate>
        <title>H.R. 6432, Animal Drug User Fee Amendments of 2008</title>
        <url>https://www.cbo.gov/publication/20116</url>
        <description>Cost estimate for the bill as ordered reported by the House Committee on Energy and Commerce on July 16, 2008</description>
      </item>
    </cboCostEstimates>
    <laws>
      <item>
        <type>Public Law</type>
        <number>110-316</number>
      </item>
    </laws>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative fees</name>
        </item>
        <item>
          <name>Administrative remedies</name>
        </item>
        <item>
          <name>Agriculture and Food</name>
        </item>
        <item>
          <name>Animals</name>
        </item>
        <item>
          <name>Antibiotics</name>
        </item>
        <item>
          <name>Civil Rights and Liberties, Minority Issues</name>
        </item>
        <item>
          <name>Clinical trials</name>
        </item>
        <item>
          <name>Commerce</name>
        </item>
        <item>
          <name>Congress</name>
        </item>
        <item>
          <name>Congressional reporting requirements</name>
        </item>
        <item>
          <name>Data banks</name>
        </item>
        <item>
          <name>Drug approvals</name>
        </item>
        <item>
          <name>Drug resistance in microorganisms</name>
        </item>
        <item>
          <name>Drugs</name>
        </item>
        <item>
          <name>Economics and Public Finance</name>
        </item>
        <item>
          <name>Food safety</name>
        </item>
        <item>
          <name>Generic drugs</name>
        </item>
        <item>
          <name>Government Operations and Politics</name>
        </item>
        <item>
          <name>Government publicity</name>
        </item>
        <item>
          <name>Law</name>
        </item>
        <item>
          <name>Livestock</name>
        </item>
        <item>
          <name>Meat</name>
        </item>
        <item>
          <name>Right of petition</name>
        </item>
        <item>
          <name>Science, Technology, Communications</name>
        </item>
        <item>
          <name>User charges</name>
        </item>
        <item>
          <name>Veterinary medicine</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2008-07-08</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2008-08-15T20:26:47Z</updateDate>
        <text><![CDATA[ <p>Animal Drug User Fee Amendments of 2008 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to assess a partial fee for a new drug application for a drug that combines active ingredients that have been approved separately.</p><p>Sets forth the amount of revenue that animal drug fees are to generate for FY2009-FY2013.</p><p>Reauthorizes appropriations for animal drug fees for FY2009-FY2013.</p><p>Requires the Secretary to report to Congress and make publicly available information on: (1) progress toward the goal of expediting the animal drug development process and the review of animal drug applications; and (2) the implementation of the authority for and use of animal drug fees.</p><p>Sets forth a process for the Secretary to develop recommendations for the process of review of animal drug applications after FY2013.</p><p>Specifies the reporting period and due date for periodic drug experience reports on antibiotic new animal drugs.</p><p>Terminates the authority to assess and use animal drug fees on October 1, 2013.</p>]]></text>
      </summary>
      <summary>
        <versionCode>36</versionCode>
        <actionDate>2008-07-30</actionDate>
        <actionDesc>Passed House amended</actionDesc>
        <updateDate>2008-08-15T20:50:17Z</updateDate>
        <text><![CDATA[ <p><b>Title I: Animal Drug User Fee Amendments</b> - Animal Drug User Fee Amendments of 2008 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act to revise definitions, including defining the &quot;process for the review of animal drug applications&quot; to include the review of advertising and labeling prior to an approval of an animal drug application or supplemental animal application after the animal drug has been approved.</p><p>(Sec. 103) Requires the Secretary of Health and Human Services to assess 50% of the standard fee for a new animal drug application for a drug that combines active ingredients that have been approved separately.</p><p>Sets forth the amount of revenue that animal drug application fees, supplemental and other animal drug application fees, product fees, establishment fees, and sponsor fees are to generate for FY2009-FY2013.</p><p>(Sec. 104) Requires the Secretary to report to Congress and make publicly available information on: (1) progress toward the goal of expediting the animal drug development process and the review of animal drug applications; and (2) implementation of the authority for and use of animal drug fees.</p><p>Sets forth a process for the Secretary to develop recommendations for the process of review of animal drug applications after FY2013.</p><p>(Sec. 105) Requires the sponsor of any new animal drug that contains an antimicrobial active ingredient to annually report to the Secretary on the amount of each antimicrobial active ingredient in the drug that is sold or distributed for use in food-producing animals, including information on any distributor-labeled product. Authorizes the Secretary to share such information with the Antimicrobial Resistance Task Force.</p><p>(Sec. 108) Terminates the authority to collect and assess animal drug fees on October 1, 2013. Terminates reporting requirements on January 31, 2014.</p><p><b>Title II: Animal Generic Drug User Fee</b> - Animal Generic Drug User Fee Act of 2008 - (Sec. 202) Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary to assess and collect fees for an abbreviated application for a generic new animal drug, including application fees, product fees, and sponsor fees.</p><p>Sets forth total revenue to be collected for each type of fee for FY2009-FY2013.</p><p>Provides for fee adjustments. Requires the Secretary to establish such fees each fiscal year.</p><p>Provides for fee waivers where the Secretary finds that the generic new animal drug is intended solely to provide for a minor use or minor species indication.</p><p>Authorizes appropriations for FY2009-FY2013.</p><p>(Sec. 203) Requires the Secretary to report to Congress and make publicly available information on: (1) progress toward the goal of expediting the generic new animal drug development process and the review of abbreviated applications for such drugs; and (2) the implementation of the authority for and use of generic new animal drug fees.</p><p>Sets forth the process for developing recommendations to present to Congress for the review of abbreviated applications for generic new animal drugs after FY2013.</p><p>(Sec. 204) Terminates the authority to assess and use generic new animal drug fees on October 1, 2013. Terminates reporting requirements on January 31, 2014.</p><p><b>Title III: Technical Corrections to FDAAA</b> - (Sec. 301) Amends the Federal Food, Drug, and Cosmetic Act to require that consideration of a citizen petition or a petition for a stay of agency action on a new drug application be separate and apart from review and approval of any such application.</p><p>(Sec. 302) Amends the Public Health Service Act to make technical corrections to provisions related to the clinical trials data bank. </p>]]></text>
      </summary>
      <summary>
        <versionCode>82</versionCode>
        <actionDate>2008-08-01</actionDate>
        <actionDesc>Passed Senate without amendment</actionDesc>
        <updateDate>2008-08-15T20:50:39Z</updateDate>
        <text><![CDATA[ <p><b>(This measure has not been amended since it was passed by the House on July 30, 2008. The summary of that version is repeated here.)</b></p><p><b>Title I: Animal Drug User Fee Amendments</b> - Animal Drug User Fee Amendments of 2008 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act to revise definitions, including defining the &quot;process for the review of animal drug applications&quot; to include the review of advertising and labeling prior to an approval of an animal drug application or supplemental animal application after the animal drug has been approved.</p><p>(Sec. 103) Requires the Secretary of Health and Human Services to assess 50% of the standard fee for a new animal drug application for a drug that combines active ingredients that have been approved separately.</p><p>Sets forth the amount of revenue that animal drug application fees, supplemental and other animal drug application fees, product fees, establishment fees, and sponsor fees are to generate for FY2009-FY2013.</p><p>(Sec. 104) Requires the Secretary to report to Congress and make publicly available information on: (1) progress toward the goal of expediting the animal drug development process and the review of animal drug applications; and (2) implementation of the authority for and use of animal drug fees.</p><p>Sets forth a process for the Secretary to develop recommendations for the process of review of animal drug applications after FY2013.</p><p>(Sec. 105) Requires the sponsor of any new animal drug that contains an antimicrobial active ingredient to annually report to the Secretary on the amount of each antimicrobial active ingredient in the drug that is sold or distributed for use in food-producing animals, including information on any distributor-labeled product. Authorizes the Secretary to share such information with the Antimicrobial Resistance Task Force.</p><p>(Sec. 108) Terminates the authority to collect and assess animal drug fees on October 1, 2013. Terminates reporting requirements on January 31, 2014.</p><p><b>Title II: Animal Generic Drug User Fee</b> - Animal Generic Drug User Fee Act of 2008 - (Sec. 202) Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary to assess and collect fees for an abbreviated application for a generic new animal drug, including application fees, product fees, and sponsor fees.</p><p>Sets forth total revenue to be collected for each type of fee for FY2009-FY2013.</p><p>Provides for fee adjustments. Requires the Secretary to establish such fees each fiscal year.</p><p>Provides for fee waivers where the Secretary finds that the generic new animal drug is intended solely to provide for a minor use or minor species indication.</p><p>Authorizes appropriations for FY2009-FY2013.</p><p>(Sec. 203) Requires the Secretary to report to Congress and make publicly available information on: (1) progress toward the goal of expediting the generic new animal drug development process and the review of abbreviated applications for such drugs; and (2) the implementation of the authority for and use of generic new animal drug fees.</p><p>Sets forth the process for developing recommendations to present to Congress for the review of abbreviated applications for generic new animal drugs after FY2013.</p><p>(Sec. 204) Terminates the authority to assess and use generic new animal drug fees on October 1, 2013. Terminates reporting requirements on January 31, 2014.</p><p><b>Title III: Technical Corrections to FDAAA</b> - (Sec. 301) Amends the Federal Food, Drug, and Cosmetic Act to require that consideration of a citizen petition or a petition for a stay of agency action on a new drug application be separate and apart from review and approval of any such application.</p><p>(Sec. 302) Amends the Public Health Service Act to make technical corrections to provisions related to the clinical trials data bank.</p>]]></text>
      </summary>
      <summary>
        <versionCode>49</versionCode>
        <actionDate>2008-08-14</actionDate>
        <actionDesc>Public Law</actionDesc>
        <updateDate>2008-08-20T13:46:34Z</updateDate>
        <text><![CDATA[ <p><b>(This measure has not been amended since it was passed by the House on July 30, 2008. The summary of that version is repeated here.)</b></p> <p><b>Title I: Animal Drug User Fee Amendments</b> - Animal Drug User Fee Amendments of 2008 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act to revise definitions, including defining the &quot;process for the review of animal drug applications&quot; to include the review of advertising and labeling prior to an approval of an animal drug application or supplemental animal application after the animal drug has been approved.</p><p>(Sec. 103) Requires the Secretary of Health and Human Services to assess 50% of the standard fee for a new animal drug application for a drug that combines active ingredients that have been approved separately.</p><p>Sets forth the amount of revenue that animal drug application fees, supplemental and other animal drug application fees, product fees, establishment fees, and sponsor fees are to generate for FY2009-FY2013.</p><p>(Sec. 104) Requires the Secretary to report to Congress and make publicly available information on: (1) progress toward the goal of expediting the animal drug development process and the review of animal drug applications; and (2) implementation of the authority for and use of animal drug fees.</p><p>Sets forth a process for the Secretary to develop recommendations for the process of review of animal drug applications after FY2013.</p><p>(Sec. 105) Requires the sponsor of any new animal drug that contains an antimicrobial active ingredient to annually report to the Secretary on the amount of each antimicrobial active ingredient in the drug that is sold or distributed for use in food-producing animals, including information on any distributor-labeled product. Authorizes the Secretary to share such information with the Antimicrobial Resistance Task Force.</p><p>(Sec. 108) Terminates the authority to collect and assess animal drug fees on October 1, 2013. Terminates reporting requirements on January 31, 2014.</p><p><b>Title II: Animal Generic Drug User Fee</b> - Animal Generic Drug User Fee Act of 2008 - (Sec. 202) Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary to assess and collect fees for an abbreviated application for a generic new animal drug, including application fees, product fees, and sponsor fees.</p><p>Sets forth total revenue to be collected for each type of fee for FY2009-FY2013.</p><p>Provides for fee adjustments. Requires the Secretary to establish such fees each fiscal year.</p><p>Provides for fee waivers where the Secretary finds that the generic new animal drug is intended solely to provide for a minor use or minor species indication.</p><p>Authorizes appropriations for FY2009-FY2013.</p><p>(Sec. 203) Requires the Secretary to report to Congress and make publicly available information on: (1) progress toward the goal of expediting the generic new animal drug development process and the review of abbreviated applications for such drugs; and (2) the implementation of the authority for and use of generic new animal drug fees.</p><p>Sets forth the process for developing recommendations to present to Congress for the review of abbreviated applications for generic new animal drugs after FY2013.</p><p>(Sec. 204) Terminates the authority to assess and use generic new animal drug fees on October 1, 2013. Terminates reporting requirements on January 31, 2014.</p><p><b>Title III: Technical Corrections to FDAAA</b> - (Sec. 301) Amends the Federal Food, Drug, and Cosmetic Act to require that consideration of a citizen petition or a petition for a stay of agency action on a new drug application be separate and apart from review and approval of any such application.</p><p>(Sec. 302) Amends the Public Health Service Act to make technical corrections to provisions related to the clinical trials data bank.</p>]]></text>
      </summary>
    </summaries>
    <title>To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the animal drug user fee program, to establish a program of fees relating to generic new animal drugs, to make certain technical corrections to the Food and Drug Administration Amendments Act of 2007, and for other purposes.</title>
    <titles>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Animal Drug User Fee Amendments of 2008</title>
      </item>
      <item>
        <titleType>Short Titles as Passed House for portions of this bill</titleType>
        <title>Animal Generic Drug User Fee Act of 2008</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Passed House for portions of this bill</titleType>
        <title>Animal Drug User Fee Amendments of 2008</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Passed Senate for portions of this bill</titleType>
        <title>Animal Generic Drug User Fee Act of 2008</title>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Passed Senate for portions of this bill</titleType>
        <title>Animal Drug User Fee Amendments of 2008</title>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Enacted for portions of this bill</titleType>
        <title>Animal Generic Drug User Fee Act of 2008</title>
      </item>
      <item>
        <titleType>Short Titles as Enacted for portions of this bill</titleType>
        <title>Animal Drug User Fee Amendments of 2008</title>
      </item>
      <item>
        <titleType>Display Title</titleType>
        <title>To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the animal drug user fee program, to establish a program of fees relating to generic new animal drugs, to make certain technical corrections to the Food and Drug Administration Amendments Act of 2007, and for other purposes.</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the animal drug user fee program, and for other purposes.</title>
      </item>
      <item>
        <titleType>Official Titles as Amended by House</titleType>
        <title>To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the animal drug user fee program, to establish a program of fees relating to generic new animal drugs, to make certain technical corrections to the Food and Drug Administration Amendments Act of 2007, and for other purposes.</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Enrolled Bill</type>
        <date>2008-08-01T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-110hr6432enr/xml/BILLS-110hr6432enr.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Received in Senate</type>
        <date>2008-07-31T04:00:00Z</date>
        <formats/>
      </item>
      <item>
        <type>Engrossed in House</type>
        <date>2008-07-30T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-110hr6432eh/xml/BILLS-110hr6432eh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Reported in House</type>
        <date>2008-07-30T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-110hr6432rh/xml/BILLS-110hr6432rh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in House</type>
        <date>2008-07-08T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-110hr6432ih/xml/BILLS-110hr6432ih.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <date>2008-08-15T03:59:59Z</date>
        <formats/>
        <type>Public Law</type>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2008-08-14</actionDate>
      <text>Became Public Law No: 110-316.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
